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Abstract
Each year, more than 2 million Americans suffer from acute cardiovascular events that account for 
approximately one-fourth of the total cost of inpatient hospital care (1). Control of low-density 
lipoprotein cholesterol (LDL–C) has been shown to substantially reduce cardiovascular disease 
morbidity and mortality (2). High LDL–C is LDL cholesterol above the treatment goals 
established by the National Cholesterol Education Program’s Adult Treatment Panel III 
guidelines. It can be managed with lifestyle changes, medications, or a combination of these 
approaches (3). A diet low in saturated fat is recognized as one of the most effective lifestyle 
changes to decrease high LDL–C (4). This report evaluates the trends in high LDL–C, use of 
cholesterol-lowering medication, and low dietary saturated-fat intake from 1976–1980 through 
2007–2010 among adults aged 40–74.
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The prevalence of high LDL–C decreased from 1976–1980 to 2007–2010
• Overall, the prevalence of high LDL–C significantly decreased from 59% in 1976–
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• Between 1976–1980 and 2007–2010, the prevalence of high LDL–C significantly 
decreased for men (65% to 31%), women (54% to 24%), and adults aged 40–64 
(56% to 27%) and 65–74 (72% to 30%) (Figure 1).
The use of cholesterol-lowering medications increased from 1976–1980 
through 2007–2010
• No data on cholesterol-lowering medications were collected in the 1976–1980 
study cycle. However, other data sources indicate that less than 1% of the 
population used lipid-lowering medication during the 1976–1980 time frame (5).
• The use of cholesterol-lowering medication grew from 5% in 1988–1994 to 17% in 
2001–2004, and reached 23% in 2007–2010 (Figure 2).
• From 1988–1994 through 2007–2010, the use of cholesterol-lowering medication 
significantly increased for men (5% to 25%), women (6% to 21%), and adults aged 
40–64 (4% to 19%) and 65–74 (10% to 39%).
An increased percentage of adults met guidelines for low saturated-fat 
intake from 1976–1980 to 1988–1994, but the percentage remained 
unchanged from 1988–1994 through 2007–2010
• The percentage of adults meeting guidelines for low saturated-fat intake increased 
significantly from 1976–1980 to 1988–1994, from 25% to 41%, but no significant 
change occurred from 1988–1994 through 2007–2010 (Figure 3).
• Between 1988–1994 and 2007–2010, the percentage of adults consuming a diet low 
in saturated fat did not change significantly for men, women, and age groups 40–64 
and 65–74.
Trends are apparent in the prevalence of high LDL–C levels, medication 
use, and dietary intake of low saturated fat
When high LDL–C, cholesterol-lowering medication use, and low saturated-fat intake 
during the time frame of 1976–1980 through 2007–2010 are presented together, the 
following patterns can be seen (Figure 4):
• Among U.S. adults aged 40–74, a substantial decline in the prevalence of high 
LDL–C, from 59% to 27%, was observed between 1976–1980 and 2007–2010.
• Significant increases are found in the percentage of adults with low dietary 
saturated-fat intake, from 25% to 41%, between 1976–1980 and 2007–2010. 
However, no significant changes were observed from 1988–1994 to 2007–2010. 
These changes were consistent among all population subgroups defined by sex and 
age (Figure 3).
• In contrast, use of cholesterol-lowering medication continued to grow steadily, 
from 5% to 23%, between 1988–1994 and 2007–2010.
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From 1976–1980 through 2007–2010, for U.S. adults aged 40–74, a decrease was observed 
in the prevalence of high LDL–C, as well as an increase in adults using lipid-lowering 
medications and consuming a diet low in saturated fat. A substantial decline in the 
prevalence of high LDL–C from 59% to 28% was seen over this same time period. There 
also were significant increases in the percentage of adults meeting federal dietary guidelines 
(6) for low dietary saturated-fat intake, from 25% to 42%, between 1976–1980 and 2007–
2010; however, no significant changes were observed from 1988–1994 to 2007–2010. 
Although declines in the proportion of calories from saturated fat have occurred since the 
1970s, the average dietary energy intake has increased (7). Use of cholesterol-lowering 
medication continued to grow steadily, from 5% to 23%, from 1988–1994 to 2007–2010.
Despite recent advances in medical treatment, high cholesterol remains a significant public 
health problem in the United States, with more than one-quarter of adults aged 40–74 having 
high LDL–C. These findings may provide useful information for evaluation of programs and 
policy initiatives aimed at reducing the prevalence of high cholesterol in the adult 
population.
Definitions
Note: For all definitions listed, the denominator is total population.
High LDL cholesterol (LDL–C
Measured levels of LDL–C above the treatment goals established by the National 
Cholesterol Education Program’s Adult Treatment Panel (ATP) III guidelines: less than 160 
milligrams per deciliter (mg/dL) for low-risk groups, less than 130 mg/dL for intermediate-
risk groups, and less than 100 mg/dL for high-risk groups (3). Persons defined as having 
high LDL–C may or may not have been taking medication.
Use of cholesterol-lowering medication
Interviewed participants were identified as current users of cholesterol-lowering medication 
if they answered “yes” to the question: “To lower your blood cholesterol, are you now 
following this advice to take prescribed medicine?” Note that data on the use of cholesterol-
lowering medication are not available for the second National Health and Nutrition 
Examination Survey (NHANES II), 1976–1980.
Low saturated-fat intake
Meeting ATP guidelines for consumption of less than 10% of total kilocalories from 
saturated fat (6), specifically the 24-hour period prior to the dietary recall interview 
(midnight to midnight), where total kilocalorie intake includes kilocalories from protein, 
carbohydrate, total fat, and alcohol. Standard conversion factors were used to convert grams 
of saturated fat to kilocalories: 9 kilocalories per gram. The percentage of kilocalories from 
saturated fat was then calculated by dividing the caloric intake from saturated fat by the total 
daily caloric intake, and multiplying this fraction by 100.
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Data source and methods
Data from NHANES conducted during four study cycles—1976–1980, 1988–1994, 2001–
2004, and 2007–2010—for adults aged 40–74 were used in this report. NHANES is a cross-
sectional survey designed to monitor the health and nutritional status of the civilian 
noninstitutionalized U.S. population. The survey consists of interviews conducted in 
participants’ homes and standardized physical examinations in mobile examination centers 
(MECs), including laboratory tests. One-half of participants aged 12 and over who 
participated in the MEC exam were randomly assigned to the morning sample and instructed 
to fast for at least 8 hours up to 24 hours prior to venipuncture. The prevalences of high 
LDL–C are based on persons examined in the morning and fasting for 8.5 up to 24 hours 
prior to venipuncture. The dietary saturated-fat data for this report were collected from in-
person, 24-hour dietary recall interviews in the MEC. Dietary recalls cover intake during the 
day (24 hours) prior to the standardized physical examination at the MEC. Improvement in 
dietary intake methodology and food composition databases, as well as changes in food 
composition, occurred during the time frame of 1976–1980 through 2007–2010 (7).
All variances were estimated by Taylor series linearization. Prevalence estimates were age 
adjusted by the direct method to the 2000 U.S. census population using the age groups 40–
59 and 60–74. The following sample weights were incorporated in prevalence estimates and 
standard errors: fasting subsample weights for high LDL–C; interview weights for 
cholesterol medication use; MEC weights for saturated-fat intake estimates for 1976–1980 
and 1988–1994; and dietary day-one weights for 2001–2004 and 2007–2010. Differences 
between groups were tested using a t statistic with the appropriate number of degrees of 
freedom at the p < 0.05 significance level. Adjustments were not made for multiple 
comparisons. Statistical hypotheses of no linear trends were tested using orthogonal 
contrasts matrices. Statistical analyses were conducted using SAS release 9.3 (SAS Institute, 
Cary, N.C.) and SUDAAN release 10.0 (RTI International, Research Triangle Park, N.C.).
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Data from the National Health and Nutrition Examination Survey, 1976–1980, 
1988–1994, 2001–2004, and 2007–2010
For adults aged 40–74:
• The prevalence of high low-density lipoprotein cholesterol, or LDL–C, 
decreased from 59% to 27% from the late 1970s through 2007–2010.
• The percentage of adults using cholesterol-lowering medication increased from 
5% to 23% from the late 1980s through 2007–2010.
• The percentage of adults consuming a diet low in saturated fat increased from 
25% to 41% from the late 1970s through 1988–1994.
• No significant changes in the percentage of adults consuming a diet low in 
saturated fat were observed from 1988–1994 through 2007–2010.
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Age-adjusted prevalence of high LDL cholesterol among adults aged 40–74, by sex and age: 
United States, 1976–1980 to 2007–2010
1Significant decreasing linear trend (p < 0.05).
NOTES: High LDL cholesterol is measured levels above the treatment goals established by 
the National Cholesterol Education Program's Adult Treatment Panel III guidelines. 
Estimates are age adjusted by the direct method to the 2000 U.S. census population using 
age groups 40–64 and 65–74.
SOURCE: CDC/NCHS, National Health and Nutrition Examination Survey.
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Use of cholesterol-lowering medications among adults aged 40–74 (age adjusted): United 
States, 1988–1994 to 2007–2010
1Significant decreasing linear trend (p < 0.05).
NOTE: Estimates are age adjusted by the direct method to the 2000 U.S. census population 
using age groups 40–64 and 65–74.
SOURCE: CDC/NCHS, National Health and Nutrition Examination Survey.
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Percentage of adults aged 40–74 meeting guidelines for low saturated-fat intake (age 
adjusted): United States, 1976–1980 to 2007–2010
1p < 0.05 for changes between 1976–1980 and 1988–1994.
NOTES: See “Definitions” section for low saturated-fat intake parameters and “Data source 
and methods” section regarding dietary recall methodology and food database changes 
between surveys. Estimates are age adjusted by the direct method to the 2000 U.S. census 
population using age groups 40–64 and 65–74.
SOURCE: CDC/NCHS, National Health and Nutrition Examination Survey.
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Age-adjusted trends in prevalence of high LDL cholesterol, use of cholesterol-lowering 
medications, and low saturated-fat intake among adults aged 40–74: United States, 1976–
1980 to 2007–2010
1Significant decreasing linear trends from 1976–1980 to 2007–2010 (p < 0.05).
2Significant increase from 1976–1980 to 1988–1994 (p < 0.05); no significant change from 
1988–1994 to 2007–2010.
3Significant increasing trend from 1988–1994 to 2007–2010.
NOTES: Data on the use of cholesterol-lowering medication was not collected in 1976–
1980. High low-density lipoprotein (LDL) cholesterol is measured levels above the 
treatment goals established by the National Cholesterol Education Program's Adult 
Treatment Panel III guidelines. Estimates are age adjusted by the direct method to the 2000 
U.S. census population using age groups 40–64 and 65–74.
SOURCE: CDC/NCHS, National Health and Nutrition Examination Survey
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